Sumitomo Mitsui Financial Group, Inc. Amgen Inc Transaction History

Sumitomo Mitsui Financial Group, Inc.

$7.43 Billion
Q4 2024

A detailed history of Sumitomo Mitsui Financial Group, Inc. transactions in Amgen Inc stock. As of the latest transaction made, Sumitomo Mitsui Financial Group, Inc. holds 55,868 shares of AMGN stock, worth $17.8 Million. This represents 0.2% of its overall portfolio holdings.

Number of Shares

55,868

Previous 52,234 6.96%

Holding current value

$17.8 Million

Previous $16.8 Million 13.48%

% of portfolio

0.2%

Previous 0.43%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 13, 2025	BUY	$258.78 - $328.31 $940,406 - $1.19 Million	3,634 Added 6.96%	55,868 $14.6 Million
Q3 2024 Nov 08, 2024	BUY	$309.38 - $337.38 $1.1 Million - $1.2 Million	3,571 Added 7.34%	52,234 $16.8 Million
Q2 2024 Aug 13, 2024	BUY	$262.75 - $319.31 $833,180 - $1.01 Million	3,171 Added 6.97%	48,663 $15.2 Million
Q1 2024 May 13, 2024	BUY	$268.87 - $324.56 $958,252 - $1.16 Million	3,564 Added 8.5%	45,492 $12.9 Million
Q4 2023 Feb 08, 2024	BUY	$255.7 - $288.46 $70,573 - $79,614	276 Added 0.66%	41,928 $12.1 Million
Q3 2023 Nov 08, 2023	BUY	$218.65 - $271.46 $137,968 - $171,291	631 Added 1.54%	41,652 $11.2 Million
Q2 2023 Aug 09, 2023	BUY	$214.27 - $253.37 $944,502 - $1.12 Million	4,408 Added 12.04%	41,021 $9.11 Million
Q1 2023 May 11, 2023	BUY	$225.79 - $275.2 $678,047 - $826,425	3,003 Added 8.93%	36,613 $8.85 Million
Q4 2022 Feb 10, 2023	BUY	$229.03 - $291.01 $287,890 - $365,799	1,257 Added 3.89%	33,610 $8.83 Million
Q3 2022 Nov 08, 2022	SELL	$224.46 - $253.15 $38,607 - $43,541	-172 Reduced 0.53%	32,353 $7.29 Million
Q2 2022 Aug 09, 2022	SELL	$230.71 - $256.74 $212,253 - $236,200	-920 Reduced 2.75%	32,525 $7.91 Million
Q1 2022 May 12, 2022	BUY	$219.27 - $242.57 $26,093 - $28,865	119 Added 0.36%	33,445 $8.09 Million
Q4 2021 Feb 10, 2022	BUY	$198.88 - $227.6 $1.09 Million - $1.25 Million	5,503 Added 19.78%	33,326 $7.5 Million
Q3 2021 Nov 10, 2021	BUY	$212.27 - $248.7 $901,722 - $1.06 Million	4,248 Added 18.02%	27,823 $5.92 Million
Q2 2021 Aug 11, 2021	BUY	$233.58 - $259.14 $605,672 - $671,950	2,593 Added 12.36%	23,575 $5.75 Million
Q1 2021 May 13, 2021	BUY	$221.91 - $258.6 $647,311 - $754,336	2,917 Added 16.15%	20,982 $5.22 Million
Q4 2020 Feb 12, 2021	SELL	$216.38 - $257.67 $446,175 - $531,315	-2,062 Reduced 10.24%	18,065 $4.15 Million
Q3 2020 Nov 12, 2020	BUY	$234.65 - $260.95 $381,540 - $424,304	1,626 Added 8.79%	20,127 $5.12 Million
Q2 2020 Aug 14, 2020	SELL	$197.81 - $242.74 $50,441 - $61,898	-255 Reduced 1.36%	18,501 $4.36 Million
Q1 2020 May 14, 2020	BUY	$182.24 - $241.7 $710,918 - $942,871	3,901 Added 26.26%	18,756 $3.8 Million
Q4 2019 Feb 14, 2020	SELL	$189.21 - $243.2 $2,270 - $2,918	-12 Reduced 0.08%	14,855 $3.58 Million
Q3 2019 Nov 08, 2019	BUY	$174.11 - $208.62 $251,240 - $301,038	1,443 Added 10.75%	14,867 $2.88 Million
Q2 2019 Aug 09, 2019	SELL	$166.7 - $195.41 $101,020 - $118,418	-606 Reduced 4.32%	13,424 $2.47 Million
Q1 2019 May 14, 2019	SELL	$180.87 - $203.88 $180,689 - $203,676	-999 Reduced 6.65%	14,030 $2.67 Million
Q4 2018 Feb 08, 2019	SELL	$178.4 - $208.25 $41,032 - $47,897	-230 Reduced 1.51%	15,029 $2.87 Million
Q3 2018 Nov 09, 2018	SELL	$185.29 - $208.89 $68,742 - $77,498	-371 Reduced 2.37%	15,259 $3.16 Million
Q2 2018 Aug 14, 2018	BUY	$166.05 - $186.51 $459,294 - $515,886	2,766 Added 21.5%	15,630 $2.89 Million
Q1 2018 May 14, 2018	BUY	$169.43 - $198.0 $473,048 - $552,816	2,792 Added 27.72%	12,864 $2.19 Million
Q4 2017 Feb 13, 2018	BUY	$168.79 - $188.59 $143,133 - $159,924	848 Added 9.19%	10,072 $1.75 Million
Q3 2017 Nov 13, 2017	BUY	$167.29 - $191.0 $1.54 Million - $1.76 Million	9,224	9,224 $1.72 Million

Others Institutions Holding AMGN

# of Institutions

3,172

Shares Held

419M

Call Options Held

8.25M

Put Options Held

6.39M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $170B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sumitomo Mitsui Financial Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Sumitomo Mitsui Financial Group, Inc. with notifications on news.

Account

Sumitomo Mitsui Financial Group, Inc. Amgen Inc Transaction History